Use of whole-genome sequencing to predict Mycobacterium tuberculosis drug resistance in Shanghai, China.
Adult
Amikacin
/ pharmacology
Antitubercular Agents
/ pharmacology
China
Drug Resistance, Bacterial
/ genetics
Ethambutol
/ pharmacology
Humans
Isoniazid
/ pharmacology
Male
Mycobacterium tuberculosis
/ drug effects
Ofloxacin
/ pharmacology
Rifampin
/ pharmacology
Streptomycin
/ pharmacology
Tuberculosis
/ microbiology
Whole Genome Sequencing
Drug resistance
Drug susceptibility testing
Drug-resistant tuberculosis
Whole-genome sequencing
Journal
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
ISSN: 1878-3511
Titre abrégé: Int J Infect Dis
Pays: Canada
ID NLM: 9610933
Informations de publication
Date de publication:
Jul 2020
Jul 2020
Historique:
received:
28
01
2020
revised:
14
04
2020
accepted:
17
04
2020
pubmed:
28
4
2020
medline:
4
9
2020
entrez:
28
4
2020
Statut:
ppublish
Résumé
To evaluate the performance of whole-genome sequencing (WGS) for predicting Mycobacterium tuberculosis (MTB) drug resistance. 276 rifampin-resistance tuberculosis (RR-TB) and 30 rifampicin-sensitive clinical isolates were randomly selected from patients with tuberculosis in Shanghai Pulmonary Hospital (SPH). Phenotypic drug susceptibility testing (DST) against six anti-TB drugs was performed, and WGS was used to predict the drug resistance using an online 'TB-Profiler' tool. Using phenotypic susceptibility as the gold standard, the overall sensitivities and specificities for WGS were 94.53% and 92.00% for isoniazid, 97.10% and 100.00% for rifampicin, 97.46% and 64.36% for ethambutol, 97.14% and 95.83% or streptomycin, 93.02% and 98.87% for ofloxacin, and 75.00% and 100.00% for amikacin, respectively. The concordances of WGS-based DST and phenotypic DST were: isoniazid (94.12%), rifampicin (97.39%), ethambutol (77.12%), streptomycin (96.73%), ofloxacin (96.41%) and amikacin (97.06%). WGS could be a promising approach to predict resistance to isoniazid, rifampicin, ethambutol, streptomycin, ofloxacin, and amikacin.
Identifiants
pubmed: 32339720
pii: S1201-9712(20)30256-3
doi: 10.1016/j.ijid.2020.04.039
pii:
doi:
Substances chimiques
Antitubercular Agents
0
Amikacin
84319SGC3C
Ethambutol
8G167061QZ
Ofloxacin
A4P49JAZ9H
Isoniazid
V83O1VOZ8L
Rifampin
VJT6J7R4TR
Streptomycin
Y45QSO73OB
Types de publication
Evaluation Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
48-53Informations de copyright
Copyright © 2020 The Author(s). Published by Elsevier Ltd.. All rights reserved.